Next Article in Journal
Self-Healing Properties of Bioinspired Amorphous CaCO3/Polyphosphate-Supplemented Cement
Next Article in Special Issue
2-Hydroxysorangiadenosine: Structure and Biosynthesis of a Myxobacterial Sesquiterpene–Nucleoside
Previous Article in Journal
Alkalinity and Its Consequences for the Performance of Steel-Reinforced Geopolymer Materials
Previous Article in Special Issue
LeTetR Positively Regulates 3-Hydroxylation of the Antifungal HSAF and Its Analogs in Lysobacter enzymogenes OH11
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chemical, Bioactivity, and Biosynthetic Screening of Epiphytic Fungus Zasmidium pseudotsugae

by
Gisela A. González-Montiel
1,
Elizabeth N. Kaweesa
1,2,
Nicolas Feau
3,
Richard C. Hamelin
3,4,
Jeffrey K. Stone
5 and
Sandra Loesgen
1,2,*
1
Department of Chemistry, Oregon State University, Corvallis, OR 97331, USA
2
Whitney Laboratory for Marine Bioscience and Department of Chemistry, University of Florida, St. Augustine, FL 32080, USA
3
Department of Forest and Conservation Sciences, University of British Columbia, Vancouver, BC V6T 1ZA, Canada
4
Faculté de Foresterie et Géomatique, Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec, QC G1V 0A6, Canada
5
Department of Botany and Plant Pathology, Oregon State University, Corvallis, OR 97331, USA
*
Author to whom correspondence should be addressed.
Molecules 2020, 25(10), 2358; https://doi.org/10.3390/molecules25102358
Submission received: 19 April 2020 / Revised: 12 May 2020 / Accepted: 14 May 2020 / Published: 19 May 2020

Abstract

:
We report the first secondary metabolite, 8,8′-bijuglone, obtained from pure cultures of the slow growing Douglas fir- (Pseudotsuga menziesii var. menziesii) foliage-associated fungus Zasmidium pseudotsugae. The quinone was characterized using extensive LC/MS and NMR-based spectroscopic methods. 8,8′-Bijuglone exhibited moderate antibiotic activity against Gram-positive pathogens and weak cytotoxic activity in the NCI-60 cell line panel and in our in-house human colon carcinoma (HCT-116) cell line. An analysis of the fungal genome sequence to assess its metabolic potential was implemented using the bioinformatic tool antiSMASH. In total, 36 putative biosynthetic gene clusters were found with a majority encoding for polyketides (17), followed by non-ribosomal peptides (14), terpenes (2), ribosomal peptides (1), and compounds with mixed biosynthetic origin (2). This study demonstrates that foliage associated fungi of conifers produce antimicrobial metabolites and suggests this guild of fungi may present a rich source of novel molecules.

Graphical Abstract

1. Introduction

The foliar fungal microbiome of Douglas-fir evergreen trees (Pseudotsuga menziesii var. menziesii) is a complex and diverse microbial ecosystem with underexplored chemical ecology [1,2]. Douglas-fir is an important commercial conifer species in forest plantations for timber and also most commonly used for Christmas trees in western North America, Europe, Australia, and New Zealand [3,4]. However, fungal pathogens, such as Nothophaeocryptopus gaeumannii, the causative agent of Swiss needle cast, have become a serious problem in Douglas-fir populations of western North America, where it has negatively affected the growth and production of this native conifer [2,4,5,6,7,8]. Plant-associated fungi often produce mycotoxins, or secrete effector proteins to suppress the immunity and defense mechanisms of their host [9,10,11], but the chemical interactions within fungal microbiome, ranging from mutualistic to pathogenic, are still elusive.
Herein, we focused on the Douglas-fir associated fungus Zasmidium pseudotsugae and its specialized metabolism. Both Z. pseudotsugae and N. gaeumannii are member of the Dothideomycetes Capnodiales, Mycosphaerellaceae [12] and frequently occur together in close association on Douglas-fir foliage. However, Z. pseudotsugae is a relatively benign epiphyte unlike N. gaeumannii which causes a foliage disease. While many natural products are known from Ascomycota, relatively few natural products are known from the Mycosphaerellaceae [12,13,14,15]. The best known are dothistromin, an aflatoxin related compound from Dothistroma septosporum, and metabolites from Cercospora, including perylquinones, for example the light activated phytotoxin cercosporin, and the beticolins (also called cebetins), which are polyketide derived toxins [16]. Therefore, in our continued approach to discover new chemical entities from different environments [17,18], plant-fungi communities have been shown to be an excellent source for new natural products [19,20,21,22].
Genome mining is now widely used for identification and connection of biosynthetic gene clusters (BGCs) found in microorganisms and plants to their respective specialized metabolites [23,24,25]. Bioinformatic tools have become an important complementary asset for compound-, or activity-driven natural product discovery. Here, we include the bioinformatics-based prediction of the chemical potential of Zasmidium pseudotsugae and surprisingly, 36 biosynthetic gene clusters were present in its genome. In solid-phase cultivation of the fungus, only one metabolite was produced, named 8,8′-bijuglone (1). The quinone was characterized by a combination of LC/MS and one- and two-dimensional NMR techniques and assessed for its antimicrobial and cytotoxicity activity. To our knowledge, this is the first bioactive metabolite isolated from Z. pseudotsugae.

2. Results and Discussion

2.1. Isolation and Characterization of 8,8′-Bijuglone (1)

Zasmidium pseudotsugae isolated from the needles of P. menziesii var. menziesii was grown on 2% malt-based agar for six months. The plate was then extracted with ethyl acetate and the agar culture extract was analyzed by LC/MS which revealed only one dominant metabolite eluting at a retention time of 21 min (Figure S1). Negative ionization mode gave an m/z value of 345.0 for [M − H] and 712.9 m/z for [2M − 2H + Na], while positive ionization mode detected an m/z value of 347.1 for [M + H]+. The compound was purified by semipreparative HPLC using an isocratic elution of 50% ACN/50% H2O both with 0.05% formic acid. The compound was identified as 8,8′-bijuglone (1) by 1D and 2D NMR (Table 1 and Figures S3–S7) and referenced to existing NMR data from synthesized 8,8′-bijugone [26].
The 13C NMR spectrum displayed two quaternary carbons (δC 190.83 ppm and 184.89 ppm) corresponding to the two ketones, a phenol carbon (δC 161.91 ppm) corresponding to the carbon bearing the hydroxyl, three quaternary aromatic carbons, and four aryl hydrocarbons. The 1H NMR spectrum exhibited an intramolecular hydrogen bonding proton singlet (δH 12.49 ppm) and four aryl hydrocarbon doublets. Determination of the structure of 1 required 2D NMR correlation experiments including COSY, HSQC, and HMBC. Utilizing COSY, two distinct spin systems were observed corresponding to two separate sets of aryl hydrocarbons coupling to each other. The doublet of 3-H (δH 6.92 ppm) correlated with the doublet of 2-H (δH 6.71 ppm) and the doublet of 7-H (δH 7.24 ppm) correlated with the doublet of 6-H (δH 7.31 ppm). The COSY correlations were connected with key HMBC correlations. The aryl hydrocarbons of 3-H (δH 6.92 ppm) and 2-H (δH 6.71 ppm) exhibited HMBC correlations with the two aryl ketones 1-C and 4-C (δC 190.8 ppm and 184.9 ppm), respectively. HMBC correlations between the hydroxyl 5-OH (δH 12.49 ppm) and the quaternary aromatic carbon atoms (δC 115.5 ppm and δC 124.8 ppm) supported the intramolecular hydrogen bonding next to the aryl ketone carbon atom 4-C (δC 190.8 ppm). The last two aryl hydrocarbons 6-H and 7-H (δH 7.31 ppm and δH 7.24 ppm) showed HMBC correlations with the quaternary aromatic carbon atoms 5-C and 8-C (δC 161.9 ppm and δC 135.2 ppm) establishing these two aryl hydrocarbons next to the phenol carbon (δC 161.9 ppm) versus next to the aryl ketone carbons. Since the LC/MS analysis indicted a molecular mass of 346 g/mol, the NMR spectra of 1 suggested that the quinone is a symmetrical dimer, each half containing a hydrogen bonded hydroxyl and two pairs of o-coupled aryl hydrocarbons. Thus, the connectivity of the two halves must be either a 6,6′- or 8,8′-linkage. Based on the HMBC correlations, δH 7.24 (H-7,7′) and 6.71 ppm (H-2,2′) with δC 128.3 ppm (C-8a,8a’) as well as δH 12.49 (OH-5,5′), 7.31 (H-6,6′) and 6.92 ppm (H-3,3′) with δC 115.5 ppm (C-4a,4a’), the 8,8′-linkage was suggested. Previous work by H. Laatsch showed differences in the UV absorption maxima for synthetic 8,8′-bijuglone (437 nm) versus 6,6′-bijuglone (445 nm) as well as a larger downfield shifts of the OH-signal from monomer (δH 10.83) to the dimer of ∆δH of 0.7 ppm for 8,8′-linkage as observed here [26,27]. The 8,8′-dimeric naphthoquinone represents a unique case where the proton and carbon environments are chemically and magnetically equivalent. Other fungal 1,4-naphthoquinone dimers are known that demonstrate chemical and magnetically equivalent environments in NMR experiments, including maritinone and mamegakinone [28]. Biosynthetically, biaryl natural products can be constructed from an oxidative coupling of polyketide originated monomers catalyzed by a laccase, peroxidase, or cytochrome P450 enzymes (CYP) [29]. In plants, however, most axially connected naphthoquinones are derived from the shikimate pathway, as shown for maritinone and mamegakinone, isolated from persimmon fruit tree Diospyros maritima [30,31]. Naphthoquinone biosynthesis is common in microorganism and plants and can hint to either parallel chemical evolution or gene transfer events. For many plant metabolites, the producing organism might be found in endophytes [32]. Following the established structure of 1, we wanted to determine if the fungus produced and retained 1 in its cells or if the compound was secreted. Extracts derived from fungal cells and supernatant of a liquid culture were analyzed by LC/MS. The [M-H]- ion (extract-ion chromatogram at 345 m/z) was only observed in the cell extract and not in the supernatant, suggesting that 1 is kept intracellularly and not secreted into the medium.

2.2. Genome Analysis of Z. pseudotsugae

A 43.4 Mb draft genome for Z. pseudotsugae was submitted to the genome mining software antiSMASH to generate and identify BGCs (Figure 1) [33]. A total of 36 BGCs were predicted, including 17 type 1 polyketide synthases (TIPKS), 14 non-ribosomal peptide synthetase-like (NRPS-like), two terpenes, one ribosomally synthesized peptide (fungal-RiPP) and two hybrid pathways. Of these, a few BGCs showed a match for published small molecules when searched against the Minimum Information of the Biosynthetic Gene cluster (MIBiG) database against characterized gene clusters [34]. Some matches exhibited 100% similarity to known compounds, including (-)-mellein (T1PKS), cercosporin (NRPS), aureobasidin A1 (NRPS), phomopsins (fungal-RiPP), and elsinochrome A (T1PKS) (Figure 1). Interestingly, cercosporin and elsinochrome, resemble key features of 8,8′-bijuglone (1) (highlighted in blue in Figure 1) suggesting that 1 could possibly be a precursor or shunt metabolite related to these biosynthetic pathways. Cercosporin and elsinochrome A are both light-dependent, toxic pigments from fungi. Perylenequinones are believed to play key roles as virulence factors in the chemical interactions between plant-pathogenic fungi and their hosts. Both metabolites are able to absorb light energy and can produce reactive oxygen species (ROS). A high amount of these toxins is reported to induce necrotic lesions on citrus and tobacco leaves [35,36,37]. 8,8′-bijuglone might exhibit similar functions in planta.

2.3. Antimicrobial Activity

The compound 1 was evaluated for antimicrobial activity against three Gram-positive bacteria, methicillin-resistant Staphylococcus aureus (MRSA) BAA-41, Bacillus subtilis (ATCC 49343), and Mycobacterium smegmatis (ATCC 14468), two Gram-negative bacteria, Escherichia coli (ATCC 8739) and Pseudomonas aeruginosa (ATCC 15442), and a fungal human pathogen Candida albicans (ATCC 90027) (Table 2). Since quinones like p-quinones and 1,4-naphthoquinones are known to be unstable in DMSO stock solutions due to their apparent redox sensitivity [38,39,40,41], compound 1 was solubilized in ethanol for antimicrobial activity tests. Against MRSA and B. subtilis, treatments with 1 at 125 μg/mL [360 µM] were moderately antimicrobial, yielding in 29.3% and 32.6% bacterial cell survival respectively, compared to 100% cell survival for vehicle control wells (Table 2). Other compounds similar to 1 have been reported to have antibacterial activity, including 8,8′-biplumbaign (also called maritinone) [30,42], chitranone [30] and diospyrin [43].

2.4. Cytotoxicity Activity

The fungal extract of Z. pseudotsugae was tested against the human colon carcinoma cell line HCT-116 (ATCC® CCL-247TM) in a single dose MTT based cell viability assay. The extract showed potent activity with 16% cell survival when tested at 10 µg/mL. Since the extract was highly enriched with 1, we next purified 8,8′-bijuglone and established the IC50 value against HCT-116 to be 130 µM (0.13 mM) [45 µg/mL], exhibiting only weak cytotoxicity (Figure 2). Compound 1 was submitted to the National Cancer Institute (NCI) for evaluation against their NCI-60 cancer cell line panel [44]. The compound showed selective, lethal activity against all six leukemia cancer cell lines when tested at 10 µM (Figure 3). In order to obtain an IC50 value against a panel of leukemia cancer cell lines, Dr. Tom O’Hare and his team at Huntsman Cancer Institute, Utah tested the compound against eight acute myeloid leukemia (AML) cell lines different from the ones used by the NCI. Here, purified 8,8′-bijuglone had no effect against the tested cell lines, most likely due to its redox sensitivity and limited solubility in ethanol when tested from a 10 mM stock solution. We cannot rule out that a highly potent compound in minute quantities is causing the activity in the extract. However, compound content on the extract was assessed by measuring the area under the curve of the UV absorbance at 210 nm, which exhibited 84% 8,8′-bijuglone with the remaining 20% being derived from solvent and media peaks, and 90% purity was detected at 254 and 280 nm. No other metabolites were detected using light scattering detection nor via the mass detector, but this does not rule out another bioactive metabolite. Noteworthy, fungal cultures extracted with ethyl acetate (pH = 5.5) and kept neat retained potent cytotoxic and antimicrobial activity over time.

3. Materials and Methods

3.1. General Experimental Procedures

Optical rotation was determined on a JACS P-1010 polarimeter. IR spectra were recorded on a Thermo Scientific Nicolet IR100 FTIR spectrometer. LRESIMS were recorded on Agilent 1100 series LC with MSD 1946 (LC/MS). NMR spectra were measured on a Bruker Avance III 500 MHz spectrometer, equipped with a 5 mm TXI probe, with the residual solvent used as an internal standard (CDCl3: δH 7.26, δC 77.06) [45]. Semi-preparative HPLC was performed with an Agilent 1100 Infinity HPLC system equipped with photodiode array detectors. Semi-preparative HPLC and analysis by LRESIMS used a Phenomenex Kinetex C18 column (150 mm × 4.6 mm, 5 μm). All solvents (analytical grade, LCMS grade, and HPLC grade) were from Sigma-Aldrich Corp., Fisher Scientific, and VWR International.

3.2. Foliage Sampling

At each site, foliage was collected from second- and third-year internodes on secondary branches in the upper crowns of five randomly selected 10- to 30-year-old Douglas-fir trees. From one of the five trees sampled at each of the Swiss needle cast (SNC) sites, foliage samples were also collected from the lower, mid, and upper crowns to assess within-tree diversity. The foliage was stored on ice and promptly returned to the campus of Oregon State University for storage in a cold room for no longer than 5 days prior to processing. Needles with pseudothecia were attached to the lids of Petri dishes with double-sided adhesive tape, placed over water agar, and incubated for 48–72 h. Individual ascospores were removed from the agar with sterilized forceps and transferred onto 2% malt agar (MA) (Difco Laboratories, Detroit, MI). Cultures were incubated at 18° C for a minimum of 2–6 months.

3.3. Culture Media

An amount of 2% Malt: malt extract (2% g/L) (CriterionTM Malt Extract, Hardy Diagnostic, Santa Maria, CA, USA) with no pH adjustment prior to sterilization. For agar plates 15 g/L nutrient agar was added to the culture media before sterilization. Zasmidium pseudotsugae was cultivated on 2% malt agar plates (MA) (40 × 25 mL) with a 1 cm2 piece of agar from a single culture and allowed to grow at ambient light and temperature for 5 months. Zasmidium pseudotsugae did not grow on rice solid media. Broth cultures (50 mL) were inoculated with a 1 cm2 piece of agar from the 5-month-old agar culture and allowed to grow at 28 °C on an orbital shaker at 110 rpm for 1 month. One-liter broth cultures were inoculated with 20 mL culture material from a 50 mL broth culture and allowed to grow at 28 °C on an orbital shaker at 110 rpm for 3 months.

3.4. Preparation of Organic Extracts and Vacuum Liquid Chromatography

The agar cultures were blended with an equivalent portion of ethyl acetate, while the broth cultures were extracted using equal parts ethyl acetate for 24 h with stirring. The organic layer, from either the agar cultures or broth culture, was concentrated under reduced vacuum.

3.5. Isolation and Physiochemical Properties of 8,8′-Bijuglone (1)

The ethyl acetate extract from the agar plate was subjected to semipreparative HPLC using an isocratic elution of (ACN/H2O (50:50) + 0.05% formic acid) for purification to yield 1.2 mg of compound 1.
8,8′-bijuglone (1): orange, needle-like crystal; [α]D20 = 0; IR (DCM) ~3200, 2924, 2854, 1640; 1H-NMR (500 MHz, CDCl3) and 13C-NMR (500 MHz, CDCl3) see Table 1. 1D- and 2D- NMR spectroscopic data see Supplementary Information. The molecular formula was determined as C20H10O6 based on the QTOF-HRMS with m/z 346.0477 [M] calcd. for C20H10O6 346.04829 (0.1 ppm); IR (ATIR) 2924, 2854, 1640 cm−1.

3.6. Genome Assembly and Bio-Informatics Analysis

Draft genome assembly of Z. pseudotsugae BR-8-S5 isolated from a single Douglas-fir needle (Blue river reservoir, OR; 44.157615N, 122.323W) was obtained by generating paired-end Illumina reads at the Centre d’expertise et de services Génome Québec plateform, Montreal, QC. DNA was extracted from a pure 4-week-old culture (2% Malt extract + 0.2% yeast extract) using the Qiagen DNeasy Plant Mini kit. Genomic library was constructed according to the NEBnext Ultra II DNA library preparation kit for Illumina (version 3.2) with minor modifications and sequenced on Illumina HiseqX machine. Raw sequencing reads were submitted to quality control and assembled into contigs using ABySS [46] with a range of k-mer values from 32 to 96. The best assembly was then selected based on genome size and contiguity (best N50). This de novo assembly is available in the NCBI database under Bioproject number PRJNA599411. Prediction of specialized metabolite genes clusters was established by submitting de novo assembly contigs to the antiSMASH fungal version with default parameters [33].

3.7. Antimicrobial Assays

Organic extracts and isolated compound were tested for activity in cell-based microbroth single dose assays following established protocols [18]. The antimicrobial activity was evaluated against methicillin-resistant Staphylococcus aureus (BAA-44), Bacillus subtilis (ATCC 49343), Mycobacterium smegmatis (ATCC 14468), Escherichia coli (ATCC 8739), Pseudomonas aeruginosa (ATCC 15442) and Candida albicans (ATCC 90027). Antibiotic positive controls (vancomycin, chloramphenicol, rifampicin, ampicillin, kanamycin, and amphotericin, respectively) were used at 125 µg/mL [360 µM], while DMSO or ethanol was used as negative control at 1.25% v/v. Compound (1) was prepared at 10 mg/mL in DMSO or ethanol, added to wells in duplicate at a final concentration of 125 μg/mL [360 µM].

3.8. Cytotoxicity Assay

Cytotoxic activity of organic extracts and pure compound were evaluated against a human colon carcinoma model (HCT-116, ATCC CCL-247) in cell-based assays following established protocols [47]. Effects on mammalian cell viability were determined by measuring the reduction of the tetrazolium salt MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diohenyltetrazolium bromide) by metabolically active cells. HCT-116 cells were maintained in MEM supplemented with 10% (v/v) fetal bovine serum, penicillin (100 U/mL), and streptomycin (100 µg/mL). The cell lines were incubated at 37 °C in 5% CO2. Cells were plated into 96-well plates at 7000 cells/well cell density, incubated overnight, and treated with the addition of 10 µg/mL compound and controls to each well. After 48 h, MTT (5 mg/mL in phosphate-buffered saline) was added to each well at a final concentration of 0.5 mg/mL. The plates were incubated for 2 h at 37 °C. The medium was removed, and the purple formazan product solubilized by the addition of 50 µL of DMSO. Absorbance was measured at 550 nm using the Biotek Synergy 96-well plate reader. Metabolic activity of vehicle-treated cells (0.1% v/v DMSO) was defined as 100% cell growth. Etoposide (250 µM) was used as a positive control. IC50 value for pure compound (1) was determined using a 10-point dilution dissolved in PBS + 5% ethanol.
Compound 1 was submitted to the NCI-60 panel and tested at a single dose of 10−5 M in ethanol [44]. One-dose data are reported as a mean graph of the percent growth of treated cells relative to the no drug control (Figure 3). Growth inhibition (values between 0 and 100) and lethality (values less than 0) can be extracted from the graph. 1 exhibited lethality within the leukemia panel. Effects of compound (1) on acute myeloid leukemia (AML) cells were determined at University of Utah [48]. The cytotoxicity activity was evaluated against eight AML cells: OCI-AML2, CMK, HL-60, MOLM-13, MOLM-14, KG1a, OCI-AML3, and SKM. Compound 1 was dosed up to 10 mM in ethanol, however no activity was observed at the highest concentration.

4. Conclusions

In the current study, a previously described 1,4-naphthoquinone dimer, 8,8′-bijuglone (1) was isolated for the first time from a natural source. The structure of 1 was elucidated by extensive spectroscopic analyses. 1 showed moderate antibacterial activity and potent cytotoxic activity when tested in a highly enriched extract and exhibited selective activity against leukemia cells when tested in the NCI-60 panel. However, when purified and tested against the human colon carcinoma cell line (HCT-116), only weak activity with an IC50 value of 130 µM [45 µg/mL] was observed. Naphthoquinone dimers are known to be redox sensitive with limited solubility. Current efforts are underway to stabilize the compound to allow for in-depth biological tests. Future studies aim to explore the mechanism of self-resistance of Zasmidium against 8,8′-bijuglone, as the compound was observed to be retained in the fungal cells, as well as the effects of 1 in planta. Additionally, genome analysis revealed a surprising large metabolic potential within Zasmidium pseudotsugae. To our knowledge, the current study presents the first secondary metabolite isolated from Z. pseudotsugae and is the first report of its biosynthetic potential using genome analysis approaches.

Supplementary Materials

The following are available online. Figure S1. LC/MS analysis of 8,8′-bijuglone (1); Figure S2. 1H-NMR spectrum of 8,8′-bijuglone (1); Figure S3. COSY spectrum of 8,8′-bijuglone (1); Figure S4. 13C-NMR spectrum of 8,8′-bijuglone; Figure S5. HSQC spectrum of 8,8′-bijuglone (1); Figure S6. HMBC spectrum of 8,8′-bijuglone (1); Figure S7. IR spectrum of 8,8′-bijuglone.

Author Contributions

Conceptualization, S.L. and G.A.G.-M.; methodology, G.A.G.-M. and S.L.; validation, N.F., R.C.H. and S.L.; formal analysis, G.A.G.-M.; investigation, G.A.G.-M. and E.N.K.; resources, N.F., J.K.S., S.L.; data curation, G.A.G.-M.; writing—original draft preparation, G.A.G.-M. and S.L.; writing—review and editing, G.A.G.-M., E.N.K., N.F., R.C.H., J.K.S. and S.L.; visualization, G.A.G.-M. and S.L.; supervision, S.L.; project administration, S.L.; funding, S.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by OSU start-up funds and by the National Science Foundation under grant CHE 1808717 (SL).

Acknowledgments

We like to acknowledge support by Prof. Thomas J. O’Hare, and Orlando Antelope (Huntsman Cancer Institute, University of Utah). We thank the NCI-60 program for cell viability testing. Genome sequencing was conducted under a grant from Genome Canada’s Large Scale Applied Research Project #10101.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Carroll, G. Fungal endophytes in stems and leaves: From latent pathogen to mutualistic symbiont. Ecology 1988, 69, 2–9. [Google Scholar] [CrossRef]
  2. Stone, J.K.; Capitano, B.R.; Kerrigan, J.L. The histopathology of Phaeocryptopus gaeumannii on Douglas-fir needles. Mycologia 2008, 100, 431–444. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Hansen, E.; Stone, J.; Capitano, B.; Rosso, P.; Sutton, W.; Winton, L.; Kanaskie, A.; McWilliams, M. Incidence and impact of Swiss needle cast in forest plantations of Douglas-fir in coastal Oregon. Plant Dis. 2000, 84, 773–778. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Kimberley, M.O.; Hood, I.A.; Knowles, R.L. Impact of Swiss needle-cast on growth of Douglas-fir. Phytopathology 2011, 101, 583–593. [Google Scholar] [CrossRef] [Green Version]
  5. Winton, L.; Manter, D.; Stone, J.; Hansen, E. Comparison of biochemical, molecular, and visual methods to quantify Phaeocryptopus gaeumannii in Douglas-Fir foliage. Phytopathology 2003, 93, 121–126. [Google Scholar] [CrossRef] [Green Version]
  6. Winton, L.M.; Stone, J.K.; Hansen, E.M.; Shoemaker, R. The systematic position of Phaeocryptopus gaeumannii. Mycologia 2007, 99, 240–252. [Google Scholar] [CrossRef]
  7. Bennett, P.; Stone, J. Assessments of population structure, diversity, and phylogeography of the Swiss needle cast fungus (Phaeocryptopus gaeumannii) in the US Pacific Northwest. Forests 2016, 7, 14. [Google Scholar] [CrossRef] [Green Version]
  8. Ritóková, G.; Shaw, D.; Filip, G.; Kanaskie, A.; Browning, J.; Norlander, D. Swiss needle cast in western Oregon Douglas-fir plantations: 20-year monitoring results. Forests 2016, 7, 155. [Google Scholar] [CrossRef] [Green Version]
  9. Bradshaw, R. Dothistroma (red-band) needle blight of pines and the dothistromin toxin: A review. For. Pathol. 2004, 34, 163–185. [Google Scholar] [CrossRef]
  10. Ma, L.-J.; Geiser, D.M.; Proctor, R.H.; Rooney, A.P.; O’Donnell, K.; Trail, F.; Gardiner, D.M.; Manners, J.M.; Kazan, K. Fusarium pathogenomics. Annu. Rev. Microbiol. 2013, 67, 399–416. [Google Scholar] [CrossRef] [Green Version]
  11. de Wit, P.J. Cladosporium fulvum effectors: Weapons in the arms race with tomato. Annu. Rev. Phytopathol. 2016, 54, 1–23. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Videira, S.; Groenewald, J.; Nakashima, C.; Braun, U.; Barreto, R.W.; de Wit, P.J.; Crous, P. Mycosphaerellaceae–chaos or clarity? Stud. Mycol. 2017, 87, 257–421. [Google Scholar] [CrossRef] [PubMed]
  13. Noar, R.D.; Daub, M.E. Bioinformatics prediction of polyketide synthase gene clusters from Mycosphaerella fijiensis. PLoS ONE 2016, 11, e0158471. [Google Scholar] [CrossRef] [Green Version]
  14. Medina, R.; Lucentini, C.G.; Franco, M.E.; Petroselli, G.; Rosso, J.A.; Erra-Balsells, R.; Balatti, P.A.; Saparrat, M.C. Identification of an intermediate for 1, 8-dihydroxynaphthalene-melanin synthesis in a race-2 isolate of Fulvia fulva (syn. Cladosporium fulvum). Heliyon 2018, 4, e01036. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Noar, R.D.; Daub, M.E. Transcriptome sequencing of Mycosphaerella fijiensis during association with Musa acuminata reveals candidate pathogenicity genes. BMC Genom. 2016, 17, 690. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Muria-Gonzalez, M.J.; Chooi, Y.H.; Breen, S.; Solomon, P.S. The past, present and future of secondary metabolite research in the D othideomycetes. Mol. Plant Pathol. 2015, 16, 92–107. [Google Scholar] [CrossRef]
  17. Adpressa, D.A.; Loesgen, S. Bioprospecting chemical diversity and bioactivity in a marine derived Aspergillus terreus. Chem. Biodivers. 2016, 13, 253–259. [Google Scholar] [CrossRef]
  18. Mandelare, P.E.; Adpressa, D.A.; Kaweesa, E.N.; Zakharov, L.N.; Loesgen, S. Coculture of Two Developmental Stages of a Marine-Derived Aspergillus alliaceus Results in the Production of the Cytotoxic Bianthrone Allianthrone A. J. Nat. Prod. 2018, 81, 1014–1022. [Google Scholar] [CrossRef]
  19. Gunatilaka, A.L. Natural products from plant-associated microorganisms: Distribution, structural diversity, bioactivity, and implications of their occurrence. J. Nat. Prod. 2006, 69, 509–526. [Google Scholar] [CrossRef] [Green Version]
  20. Arnold, A.E. Understanding the diversity of foliar endophytic fungi: Progress, challenges, and frontiers. Fungal Biol. Rev. 2007, 21, 51–66. [Google Scholar] [CrossRef]
  21. Kusari, S.; Hertweck, C.; Spiteller, M. Chemical ecology of endophytic fungi: Origins of secondary metabolites. Chem. Biol. 2012, 19, 792–798. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Gouda, S.; Das, G.; Sen, S.K.; Shin, H.-S.; Patra, J.K. Endophytes: A Treasure House of Bioactive Compounds of Medicinal Importance. Front. Microbiol. 2016, 7, 1538. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Sieber, C.M.; Lee, W.; Wong, P.; Münsterkötter, M.; Mewes, H.-W.; Schmeitzl, C.; Varga, E.; Berthiller, F.; Adam, G.; Güldener, U. The Fusarium graminearum genome reveals more secondary metabolite gene clusters and hints of horizontal gene transfer. PLoS ONE 2014, 9, e110311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Nielsen, J.C.; Grijseels, S.; Prigent, S.; Ji, B.; Dainat, J.; Nielsen, K.F.; Frisvad, J.C.; Workman, M.; Nielsen, J. Global analysis of biosynthetic gene clusters reveals vast potential of secondary metabolite production in Penicillium species. Nat. Microbiol. 2017, 2, 17044. [Google Scholar] [CrossRef] [PubMed]
  25. Lyu, H.-N.; Liu, H.-W.; Keller, N.P.; Yin, W.-B. Harnessing diverse transcriptional regulators for natural product discovery in fungi. Nat. Prod. Rep. 2019. [Google Scholar] [CrossRef] [PubMed]
  26. Laatsch, H. Dimere Naphthochinone, XVI. Synthese von Maritinon und anderen 8, 8′-Bijuglonen. Liebigs Annalen der Chemie 1985, 1985, 2420–2442. [Google Scholar] [CrossRef]
  27. Bao, N.; Ou, J.; Shi, W.; Li, N.; Chen, L.; Sun, J. Highly Efficient Synthesis and Structure–Activity Relationships of a Small Library of Substituted 1, 4-Naphthoquinones. Eur. J. Org. Chem. 2018, 2018, 2254–2258. [Google Scholar] [CrossRef]
  28. Tezuka, M.; Takahashi, C.; Kuroyanagi, M.; Satake, M.; Yoshihira, K.; Natori, S. New naphthoquinones from Diospyros. Phytochemistry 1973, 12, 175–183. [Google Scholar] [CrossRef]
  29. Aldemir, H.; Richarz, R.; Gulder, T.A. The biocatalytic repertoire of natural biaryl formation. Angew. Chem. Int. Ed. 2014, 53, 8286–8293. [Google Scholar] [CrossRef]
  30. Gu, J.-Q.; Graf, T.N.; Lee, D.; Chai, H.-B.; Mi, Q.; Kardono, L.B.S.; Setyowati, F.M.; Ismail, R.; Riswan, S.; Farnsworth, N.R.; et al. Cytotoxic and Antimicrobial Constituents of the Bark of Diospyros maritima Collected in Two Geographical Locations in Indonesia. J. Nat. Prod. 2004, 67, 1156–1161. [Google Scholar] [CrossRef]
  31. Higa, M.; Takashima, Y.; Yokaryo, H.; Harie, Y.; Suzuka, T.; Ogihara, K. Naphthoquinone Derivatives from Diospyros maritima. Chem. Pharm. Bull. 2017, 65, 739–745. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Lunardelli Negreiros de Carvalho, P.; de Oliveira Silva, E.; Aparecida Chagas-Paula, D.; Honorata Hortolan Luiz, J.; Ikegaki, M. Importance and implications of the production of phenolic secondary metabolites by endophytic fungi: A mini-review. Mini Rev. Med. Chem. 2016, 16, 259–271. [Google Scholar] [CrossRef] [PubMed]
  33. Blin, K.; Shaw, S.; Steinke, K.; Villebro, R.; Ziemert, N.; Lee, S.Y.; Medema, M.H.; Weber, T. antiSMASH 5.0: Updates to the secondary metabolite genome mining pipeline. Nucleic Acids Res. 2019, 47, W81–W87. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Medema, M.H.; Kottmann, R.; Yilmaz, P.; Cummings, M.; Biggins, J.B.; Blin, K.; De Bruijn, I.; Chooi, Y.H.; Claesen, J.; Coates, R.C. Minimum information about a biosynthetic gene cluster. Nat. Chem. Biol. 2015, 11, 625. [Google Scholar] [CrossRef] [PubMed]
  35. Jiao, W.; Liu, L.; Zhou, R.; Xu, M.; Xiao, D.; Xue, C. Elsinochrome phytotoxin production and pathogenicity of Elsinoë arachidis isolates in China. PLoS ONE 2019, 14, e0218391. [Google Scholar] [CrossRef] [PubMed]
  36. Chooi, Y.H.; Zhang, G.; Hu, J.; Muria-Gonzalez, M.J.; Tran, P.N.; Pettitt, A.; Maier, A.G.; Barrow, R.A.; Solomon, P.S. Functional genomics-guided discovery of a light-activated phytotoxin in the wheat pathogen Parastagonospora nodorum via pathway activation. Environ. Microbiol. 2017, 19, 1975–1986. [Google Scholar] [CrossRef]
  37. Hu, J.; Sarrami, F.; Li, H.; Zhang, G.; Stubbs, K.A.; Lacey, E.; Stewart, S.G.; Karton, A.; Piggott, A.M.; Chooi, Y.-H. Heterologous biosynthesis of elsinochrome A sheds light on the formation of the photosensitive perylenequinone system. Chem. Sci. 2019, 10, 1457–1465. [Google Scholar] [CrossRef] [Green Version]
  38. Görner, H. Photoreactions of p-Quinones with Dimethyl Sulfide and Dimethyl Sulfoxide in Aqueous Acetonitrile. Photochem. Photobiol. 2006, 82, 71–77. [Google Scholar] [CrossRef]
  39. Zhu, X.-Q.; Wang, C.-H. Accurate estimation of the one-electron reduction potentials of various substituted quinones in DMSO and CH3CN. J. Org. Chem. 2010, 75, 5037–5047. [Google Scholar] [CrossRef]
  40. Widhalm, J.R.; Rhodes, D. Biosynthesis and molecular actions of specialized 1,4-naphthoquinone natural products produced by horticultural plants. Hortic. Res. 2016, 3, 16046. [Google Scholar] [CrossRef]
  41. Elhabiri, M.; Sidorov, P.; Cesar-Rodo, E.; Marcou, G.; Lanfranchi, D.A.; Davioud-Charvet, E.; Horvath, D.; Varnek, A. Electrochemical properties of substituted 2-methyl-1,4-naphthoquinones: Redox behavior predictions. Chem.-A Eur. J. 2015, 21, 3415–3424. [Google Scholar] [CrossRef] [PubMed]
  42. Salae, A.-W.; Karalai, C.; Ponglimanont, C.; Kanjana-Opas, A.; Yuenyongsawad, S. Naphthalene derivatives from Diospyros wallichii. Can. J. Chem. 2010, 88, 922–927. [Google Scholar] [CrossRef]
  43. McGaw, L.J.; Lall, N.; Hlokwe, T.M.; Michel, A.L.; Meyer, J.J.M.; Eloff, J.N. Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria. Biol. Pharm. Bull. 2008, 31, 1429–1433. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Shoemaker, R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 2006, 6, 813. [Google Scholar] [CrossRef] [PubMed]
  45. Babij, N.R.; McCusker, E.O.; Whiteker, G.T.; Canturk, B.; Choy, N.; Creemer, L.C.; Amicis, C.V.D.; Hewlett, N.M.; Johnson, P.L.; Knobelsdorf, J.A. NMR chemical shifts of trace impurities: Industrially preferred solvents used in process and green chemistry. Org. Process Res. Dev. 2016, 20, 661–667. [Google Scholar] [CrossRef]
  46. Simpson, J.T.; Wong, K.; Jackman, S.D.; Schein, J.E.; Jones, S.J.; Birol, I. ABySS: A parallel assembler for short read sequence data. Genome Res. 2009, 19, 1117–1123. [Google Scholar] [CrossRef] [Green Version]
  47. Plitzko, B.; Kaweesa, E.N.; Loesgen, S. The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells. J. Biol. Chem. 2017, 292, 21102–21116. [Google Scholar] [CrossRef] [Green Version]
  48. Eide, C.A.; O’Hare, T. Chronic myeloid leukemia: Advances in understanding disease biology and mechanisms of resistance to tyrosine kinase inhibitors. Curr. Hematol. Malig. Rep. 2015, 10, 158–166. [Google Scholar] [CrossRef] [Green Version]
Sample Availability: Enriched extract is available on request.
Figure 1. Biosynthetic gene clusters predicted in Z. pseudotsugae identified by antiSMASH. Clusters with 100% similarity to a compound are shown on the right. The structure of 8,8′-bijuglone (1) is highlighted in blue in the core structures of cercosporin and elsinochrome.
Figure 1. Biosynthetic gene clusters predicted in Z. pseudotsugae identified by antiSMASH. Clusters with 100% similarity to a compound are shown on the right. The structure of 8,8′-bijuglone (1) is highlighted in blue in the core structures of cercosporin and elsinochrome.
Molecules 25 02358 g001
Figure 2. IC50 curve of 8,8′-bijuglone (1) against human colon carcinoma (HCT-116). The IC50 value was determined to be 130 µM (0.13 mM, 45 µg/mL).
Figure 2. IC50 curve of 8,8′-bijuglone (1) against human colon carcinoma (HCT-116). The IC50 value was determined to be 130 µM (0.13 mM, 45 µg/mL).
Molecules 25 02358 g002
Figure 3. Mean graph display of NCI-60 cell line screening data for 8,8′-bijuglone (1) (NCS 811277). Sample concentration at 10 µM. The bars to the right indicate high lethality and the bars to the left indicate growth inhibition. Experiments were performed at the NCI-DTP: http://dtp.cancer.gov [44].
Figure 3. Mean graph display of NCI-60 cell line screening data for 8,8′-bijuglone (1) (NCS 811277). Sample concentration at 10 µM. The bars to the right indicate high lethality and the bars to the left indicate growth inhibition. Experiments were performed at the NCI-DTP: http://dtp.cancer.gov [44].
Molecules 25 02358 g003
Table 1. 1H and 13C NMR of 8,8′-bijuglone (1) at 500 MHz in CDCl3.
Table 1. 1H and 13C NMR of 8,8′-bijuglone (1) at 500 MHz in CDCl3.
Compound Molecules 25 02358 i001
PositionδCTypeδH, mult (J in Hz)
1, 1′184.9C-
2, 2′140.6CH6.71, d (10.2 Hz)
3, 3′138.0 CH6.92, d (10.2 Hz)
4, 4′190.8 C-
4a, 4a′115.5C-
5, 5′161.9C-
6, 6′124.8CH7.31, d (8.7 Hz)
7, 7′138.7CH7.24, d (8.7 Hz)
8, 8′135.2C-
8a, 8a′128.3C-
5-OH, 5′-OH--12.49, s
Table 2. Antimicrobial activity of 8,8′-bijuglone (1). Percent given is cell survival after treatment. Pathogens used: methicillin-resistant Staphylococcus aureus (BAA-44) = MRSA, Bacillus subtilis (ATCC 49343), Mycobacterium smegmatis (ATCC 14468), Escherichia coli (ATCC 8739), Pseudomonas aeruginosa (ATCC 15442), Candida albicans (ATCC 90027).
Table 2. Antimicrobial activity of 8,8′-bijuglone (1). Percent given is cell survival after treatment. Pathogens used: methicillin-resistant Staphylococcus aureus (BAA-44) = MRSA, Bacillus subtilis (ATCC 49343), Mycobacterium smegmatis (ATCC 14468), Escherichia coli (ATCC 8739), Pseudomonas aeruginosa (ATCC 15442), Candida albicans (ATCC 90027).
Sample 1 Antibacterial 2 Antifungal 2
MRSABacillus subtilisMycobacterium smegmatisEscherichia coliPseudomonas aeruginosaCandida albicans
8,8′-bijuglone29.3%32.6%91.5%97.1%86.0%99.5%
positive control0.0% vancomycin15.1% chloramphenicol1.5% rifampicin11.6% ampicillin0.2% kanamycin23.6% amphotericin B
negative control> 100% ethanol68% ethanol100% DMSO89.0% ethanol92.4% ethanol100% ethanol
1 Samples and positive controls were tested to a final concentration of 125 µg/mL [360 µM]. Negative controls were tested at 1.25% ethanol, except M. smegmatis in DMSO.

Share and Cite

MDPI and ACS Style

González-Montiel, G.A.; Kaweesa, E.N.; Feau, N.; Hamelin, R.C.; Stone, J.K.; Loesgen, S. Chemical, Bioactivity, and Biosynthetic Screening of Epiphytic Fungus Zasmidium pseudotsugae. Molecules 2020, 25, 2358. https://doi.org/10.3390/molecules25102358

AMA Style

González-Montiel GA, Kaweesa EN, Feau N, Hamelin RC, Stone JK, Loesgen S. Chemical, Bioactivity, and Biosynthetic Screening of Epiphytic Fungus Zasmidium pseudotsugae. Molecules. 2020; 25(10):2358. https://doi.org/10.3390/molecules25102358

Chicago/Turabian Style

González-Montiel, Gisela A., Elizabeth N. Kaweesa, Nicolas Feau, Richard C. Hamelin, Jeffrey K. Stone, and Sandra Loesgen. 2020. "Chemical, Bioactivity, and Biosynthetic Screening of Epiphytic Fungus Zasmidium pseudotsugae" Molecules 25, no. 10: 2358. https://doi.org/10.3390/molecules25102358

Article Metrics

Back to TopTop